ArticleJournal for immunotherapy of cancer2014

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.

Minghui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.